Saamya Biotech (india) (Delisted) financials and balance sheet

BSE: 532905Pharmaceuticals & Biotechnology

Last traded ₹1.97 on 13 Aug 2018

Delisted on 13 Jul 2022.

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Saamya Biotech (india) annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹29 Cr, year to Mar 2015A loss in 6 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2019

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.0
  2. Employee costs0.0
  3. Other expenses0.0
  4. Operating profit0.0
  5. Depreciation0.0
  6. Other income0.0
  7. One-off items0.0
  8. Finance costs0.0
  9. Profit before tax0.0
  10. Tax0.0
  11. Net profit0.0

What the company owns

  • Plant, investments and other assets₹19 Cr
  • Receivables₹19 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Owed to suppliers₹47 Cr
  • Borrowings₹3 Cr

Profit and loss

Standalone, ₹ crore, years to March.Saamya Biotech (india) quarterly results

₹ croreMar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Filed 4 SepMar 2019Filed 16 Jul
Revenue from operations2.316.923.33.013.428.814.4–0.00.0
–16.622.73.313.128.514.5–0.00.0
Materials and goods bought2.216.021.32.812.728.414.4–0.00.0
Employee costs–0.1–0.10.10.10.1–0.00.0
Other expenses–0.4–0.40.30.10.1–0.00.0
Operating profit before depreciation–0.30.6−0.30.30.2−0.1–0.00.0
Operating margin–2.0%2.5%−10.0%2.2%0.8%−0.9%–––
Materials, % of revenue–94.7%–94.0%95.2%98.7%99.8%–––
Employee costs, % of revenue–0.6%–4.0%0.7%0.3%0.7%–––
Other expenses, % of revenue–2.5%–12.6%2.0%0.2%0.5%–––
Depreciation and amortisation–0.10.10.10.11.00.99.40.00.0
Operating profit after depreciation–0.30.5−0.40.2−0.8−1.0–0.00.0
Other income––0.7–0.00.00.1–0.00.0
Finance costs0.00.00.80.00.00.00.00.00.00.0
One-off items––––––––0.00.0
Profit before tax0.00.20.4−0.40.2−0.7−0.9−41.10.00.0
Tax–0.10.10.00.1−0.1−0.50.50.00.0
Net profit0.00.10.3−0.40.1−0.7−0.4−41.60.00.0
Net margin1.3%0.5%1.1%−13.4%0.7%−2.4%−3.1%–––
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2012 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2010: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2017: the statement does not state its revenue, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2018Filed 4 SepMar 2019Filed 16 Jul
−13.4−13.4
Share capital24.924.9
Reserves−38.3−38.3
Borrowings3.23.2
48.048.0
Liabilities due after a year3.23.2
Total assets37.937.9
18.618.6
19.319.3
Net debt3.23.2
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2010, Mar 2011, Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016 and Mar 2017, so its lines and the ratios worked from it are blank there.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Filed 4 SepMar 2019Filed 16 Jul
Earnings per share₹0.01₹0.04––₹0.04––−₹17.00––
Diluted earnings per share––––₹0.04––−₹17.00––
Market cap at the year end (₹ crore)–11.9––2.8–10.5–––
Earnings per share is left blank for the years to Mar 2018 and Mar 2019: the earnings per share is stated as 0 while the period's profit or loss comes to at least half a paisa a share, so the 0 stands in for a figure the filing does not give.

Ratios

Standalone, years to March.

RatioMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Filed 4 SepMar 2019Filed 16 Jul
Revenue growth621.6%37.5%−87.2%347.9%115.3%−49.9%–––
Operating profit growth–72.8%––−20.8%––––
Net profit growth183.9%186.4%–––––––
Earnings per share growth300.0%––––––––
Interest cover6.80.6–10.7–––––
Asset turnover–––––––0.000.00
Assets per rupee of net worth–––––––−2.82−2.82
Sales per rupee of plant–––––––0.000.00
Plant being built, % of plant in use–––––––10,579.3%10,574.4%
Interest cover is left blank for the years to Mar 2013, Mar 2015 and Mar 2016: operating profit after depreciation is a loss, and a loss covers no interest bill. Debt to equity is left blank for the years to Mar 2018 and Mar 2019: net worth is below zero, so there is no shareholders' money to set the borrowings against. Return on capital employed is left blank for the years to Mar 2018 and Mar 2019: net worth and borrowings together come to nought or less, so there is no money employed to set the operating profit against. No balance sheet is on record for the years to Mar 2010, Mar 2011, Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016 and Mar 2017, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2019.

Return on assets, latest year
−0.1%
Measure3 years
Asset turnover, average0.00

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Assets under construction, years of additionsOur threshold 2 years of additions––––––––2,28,248.75
Effective tax ratePublished threshold 17.16 per cent54.1731.52–37.50–––––
A threshold marked as ours has no published figure; it is the line we read the check against.